98%
921
2 minutes
20
Stormwater catch basins are commonly treated with larvicides by mosquito control agencies to reduce local populations of mosquito species capable of transmitting West Nile virus. Recent evidence suggests that extended-release larvicides formulated to last up to 180 days in catch basins may not be effective in some basins due to chronic flushing, rapid dissolution, or burying of treatment in sump debris. To investigate if increasing the number of applications could improve effectiveness, a small study was performed over 13 weeks in 2015 to evaluate two extended-release larvicides (Natular™ XRT 180-day tablets and Natular™ T30 30-day tablets) and a larvicide oil (CocoBear™). Over the course of 13 weeks, three groups of eight basins were monitored for mosquitoes, each group receiving Natular™ XRT, Natular™ T30, or CocoBear™ larvicides. All basins received a single application at the beginning of the study period. Once mosquitoes in a basin surpassed the treatment threshold during weekly monitoring, an additional application of the associated larvicide was given to that basin. The number of applications during the study period ranged from 1 to 10 for CocoBear™ basins, 1 to 7 for T30 basins, and 2 to 8 for XRT basins. Overall, the average number of applications and the cost of larvicide per basin were 4.4 applications at $0.66 per Coco-Bear™ basin, 4.4 applications at $6.26 per T30 basin, and 4 applications at $16.56 per XRT basin. Basins treated with XRT and T30 needed reapplications more often than expected, yet were no more effective than CocoBear™, suggesting that increasing the frequency of application of these larvicide formulations may not provide increased mosquito reduction in some basins.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712978 | PMC |
http://dx.doi.org/10.4137/EHI.S36722 | DOI Listing |
J Neurol Surg B Skull Base
October 2025
Department of Neurological Surgery at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Objectives: The two histologic subtypes of craniopharyngiomas (CPs), papillary and adamantinomatous, harbor mutually exclusive mutations of BRAF V600E and CTNNB1, respectively. Studies suggest that subtotal resection (STR) plus adjuvant radiation therapy (XRT) may result in similar progression-free survival (PFS) as gross total resection (GTR). We hypothesized that STR ± XRT and GTR result in similar PFS for both BRAF and β-catenin-mutated CPs.
View Article and Find Full Text PDFFront Cardiovasc Med
August 2025
Department of Internal Medicine, Yale New Heaven Health Bridgeport Hospital, Bridgeport, CT, United States.
Background: Transcatheter aortic valve replacement (TAVR) is an effective treatment for severe aortic stenosis, particularly in high-risk patients unsuitable for surgical aortic valve replacement (SAVR). However, the efficacy of TAVR in patients with radiation-induced aortic stenosis remains uncertain and controversial. This meta-analysis evaluates clinical outcomes of TAVR in patients with prior chest radiation (C-XRT).
View Article and Find Full Text PDFCancers (Basel)
August 2025
The Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Invasive BC patients are at risk of loco-regional recurrence, distant MTS, and the development of second primary tumors. SPMs comprise the sixth most common group of malignancies. The records of 125 consecutive patients with primary invasive TCC of the bladder seen in the Oncology Department of Soroka University Medical Center were reviewed between January 2016 and December 2023.
View Article and Find Full Text PDFChilds Nerv Syst
August 2025
Department of Neurosurgery, State University of Campinas, Campinas, SP, Brazil.
Background: The rapid development of technologies that allow a more precise radiation-based treatment has constantly changed the current scenario of malignant central nervous system diseases. This study aimed to compare different complications and survival rates of pediatric patients with medulloblastomas treated with proton radiation therapy (PBRT) and photon radiation therapy (XRT).
Methods: We performed a systematic review and comparative meta-analysis.
Int J Clin Oncol
August 2025
Department of Radiation Oncology, University of Tsukuba, Tsukuba, Ibaraki, 305-8576, Japan.
Introduction: Central nervous system germ cell tumors (CNS-GCTs) are rare pediatric tumors, categorized into germinomas and non-germinomatous germ cell tumors (NGGCTs). Proton-beam therapy (PBT) has been introduced as an alternative to X-ray therapy (XRT) for minimizing radiation exposure to normal brain tissue, but evidence comparing these treatment modalities is limited.
Methods: A systematic review and meta-analysis following PRISMA guidelines was conducted using PubMed for studies published between 1990 and 2022.